Dry powder aerosol delivery systems: Current and future research directions

Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung

Volumn 19, Issue 1, 2006, Pages 21-27

  Chan, Hak Kim ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Computational modelling; Dry powder inhaler (DPI); In vitro performance; Lung deposition; Particle engineering; Powder formulation

Indexed keywords

DRUG; DRUG CARRIER; EXCIPIENT; GLUCOSE; LACTOSE; LEUCINE; MAGNESIUM STEARATE; MANNITOL; SALBUTAMOL SULFATE;

ADHESION; AEROSOL; AIRWAY; ATOMIC FORCE MICROSCOPY; BREATHING PATTERN; COMPUTATIONAL FLUID DYNAMICS; CRYSTALLIZATION; DISPERSION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG MANUFACTURE; DRUG RESEARCH; DRY POWDER; ELECTRICITY; ENERGY; FORCE; HUMAN; HUMIDITY; IN VITRO STUDY; IN VIVO STUDY; INHALER; INVERSE GAS CHROMATOGRAPHY; LUNG; NUCLEAR MAGNETIC RESONANCE IMAGING; OROPHARYNX; PARTICLE SIZE; PHARMACEUTICAL ENGINEERING; PRESSURE; REVIEW; SURFACE PROPERTY;

ADMINISTRATION, INHALATION; AEROSOLS; CHEMISTRY, PHARMACEUTICAL; ELECTROSTATICS; HUMANS; HUMIDITY; LUNG; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; POWDERS; RHEOLOGY; SURFACE PROPERTIES;

EID: 33645467770     PISSN: 08942684     EISSN: None     Source Type: Journal    
DOI: 10.1089/jam.2006.19.21     Document Type: Review

References (48)

1. Chan, H.-K. 2003. Inhalation drug delivery devices and emerging technologies. Expert Opin. Ther. Patents 13:1333-1343.
2. Chan, H.-K. and N. Chew. 2003. Novel alternative methods for the delivery of drugs for asthma treatment. Adv. Drug Deliv. Rev. 55:793-805.
3. Brown, L.R., J. Rashba-Step, T. Scott, et al. 2002. Pulmonary Delivery of Novel Insulin Microspheres. in Respiratory Drug Delivery VIII. Davis Horwood International, Tucson.
4. Johnson, B.K., and R.K. Prud'homme. 2002. A process and apparatus for preparing nanoparticle compositions with amphiphilic copolymers. International Patent Publication WO2002078674.
5. Johnson, B.K. and R.K. Prud'homme. 2003. Chemical processing and micromixing in confined impinging jets. AIChE J. 49:2264-2282.
6. Chen, J.-F., C. Zheng, and G.T. Chen. 1996. Interaction of macro- and micro-mixing on particle size distribution in reaction precipitation. Chem. Eng. Sci. 51:1957-1966.
7. Chen, J.F., Y.H. Wang, F. Guo, et al. 2000. Synthesis of nanoparticles with novel technology: high-gravity reactive precipitation. Ind. Eng. Chem. Res. 39:948-954.
8. Chen, J.-F., M.-Y. Zhou, L. Shao, et al. 2004. Feasibility of preparing nanodrugs by high-gravity reactive precipitation. Int. J. Pharm. 269:267-274.
9. Chan, H.-K. and I. Gonda. 1989. Aerodynamic properties of a solid form of cromoglycic acid. J. Aerosol Sci. 20:157-168.
10. Tang, P., H.-K. Chan, and J. Raper. 2004. Prediction of aerodynamic diameter of particles with rough surfaces. Powder Technol. 147:64-78.
11. Tang, P., N. Chew, H.-K. Chan, et al. 2003. Limitation of determination of surface fractal dimension using N2 absorption isotherms and modified Frenkel-Halsey-Hill theory. Langmuir 19:2632-2638.
12. Chew, N.Y.K., P. Tang, H.-K. Chan, et al. 2005. How much particle surface corrugation is sufficient to improve aerosol performance of powders? Pharm. Res. 22:147-151.
13. Tong, H.H., B.Y. Shekunov, P. York, et al. 2001. Characterization of two polymorphe of salmeterol xinafoate crystallized from supercritcal fluids. Pharm. Res. 18:852-858.
14. Feeley, J. 2002. Powder characterization tests: Can they make a difference in product development. In Respiratory Drug Delivery VIII. Davis Horwood International, Tucson.
15. Cline, D. and R. Dalby. 2002. Predicting the quality of powders for inhalation from surface energy and area. Pharm. Res. 19:1274-1277.
16. Chew, N.Y.K., B.Y. Shekunov, H.H.Y. Tong, et al. 2005. Effect of amino acids on the dispersion of disodium cromoglycate powders. J. Pharm. Sci. 94:2289-2300.
17. Hooton, J.C. 2004. An atomic force microscopy study of the effect of nanoscale contact geometry and surface chemistry on the adhesion of pharmaceutical particles. Pharm. Res. 21:953-961.
18. Byron, P., R. Pearl, S. Joanne, et al. 1997. Aerosol electrostatics. I. Properties of fine powders before and after aerosolization by dry powder inhalers. Pharm. Res. 14:698-705.
19. Glover, W., and H.-K. Chan. 2004. Electrostatic charge characterization of pharmaceutical aerosols using electrical low-pressure impactor (ELPI). J. Aerosol Sci. 35:755-764.
20. Glover, W., and H.-K. Chan. 2004. Electrostatic charge characterization of pharmaceutical aerosols. In Respiratory Drug Delivery IX. Davis Healthcare, Palm Desert, CA.
21. Baron, P.A., M.K. Mazumder, and Y.-S. Cheng. 2001. Direct-reading techniques using particles motion and optical detection. In P.A. Baron and K. Willeke, eds. Aerosol Measurement Principles, Techniques, and Applications. Wiley-Interscience, New York, 495-527.
22. Mazumder, M.K., C.U. Yurteri, G. Ahuja, et al. 2002. Bipolar electrostatic charging of fine pharmaceutical powders by dispersion and transport processes and its implications to lung deposition of inhaled DPI aerosols. In Respiratory Drug Delivery VIII. Davis Horwood International, Raleigh, NC.
23. Bailey, A.G. 1997. The inhalation and deposition of charged particles within the human lung. J. Electrostatics 42:25-32.
24. Balachandran, W., M.W. Gaura, and C. Hudson. 1997. Control of drug aerosol in human airways using electrostatic forces. J. Electrostatics 40:579-584.
25. Melandri, C., T.G. Prodi, V. De Zaiacomo, et al. 1983. Deposition of charged particles in the human airways. J. Aerosol Sci. 14:657-669.
26. Chan, H.-K., A. Clark, I. Gonda, et al. 1997. Spray dried powders and powder blends of recombinant human deoxyribonuclease (rhDNase) for aerosol delivery. Pharm. Res. 14:431-437.
27. Lucas, P., K. Anderson, and J.N. Staniforth. 1998. Protein deposition from dry powder inhalers: fine particle multiplets as performance modifiers. Pharm. Res. 15:562-569.
28. Begat, P., D.A.V. Morton, J.N. Staniforth, et al. 2004. The cohesive-adhesive balances in dry powder inhaler formulations. I. Direct quantification by atomic force microscopy. Pharm. Res. 21:1591-1597.
29. Zeng, X.M., G.P. Martin, S.-K. Tee, et al. 1999. Effects of particle size and adding sequence of fine lactose on the deposition of salbutamol sulphate from a dry powder formulation. Int. J. Pharm. 182:133-144.
30. Louey, M.D., and P.J. Stewart. 2002. Particle interactions involved in aerosol dispersion of ternary interactive mixtures. Pharm. Res. 19:1524-1531.
31. Begat, P., D.A.V. Morton, J.N. Staniforth, et al. 2004. The cohesive-adhesive balances in dry powder inhaler formulations. II. Influence on fine particle delivery characteristics. Pharm. Res. 21:1826-1833.
32. Borgstrom, L., H. Bisgaard, C. O'Callaghan, et al. 2002. Dry-powder inhalers. In H. Bisgaard, C. O'-Callaghan, and G.C. Smaldone, eds. Drug Delivery to the Lung. Marcel Dekker, New York, 421-448.
33. Voss, A.P., and W.H. Finlay. 2002. Deagglomeration of dry powder pharmaceutical aerosols. Int. J. Pharm. 248:39-50.
34. Finlay, W.H. 2001. The Mechanics of Inhaled Pharmaceutical Aerosols. Academic Press, London.
35. Coates, M., D. Fletcher, H.-K. Chan, et al. 2004. Effect of design on the performance of a dry powder inhaler using computational fluid dynamics. Part 1. Grid structure and mouthpiece length. J. Pharm. Sci. 93:2863-2876.
36. Yang, R.Y., R.P. Zou, and A.B. Yu. 2000. Computer simulation of the packing of fine particles. Phys. Rev. E 62:3900-3907.
37. Moreno, R., M. Ghadiri, and S.J. Antony. 2003. Effect of the impact angle on the breakage of agglomerates: a numerical study using DEM. Powder Technol. 130:132-137.
38. Samimi, A., M. Ghadiri, R. Boerefijn, et al. 2003. Effect of structural characteristics on impact breakage of agglomerates. Powder Technol. 130:428-435.
39. Clark, A., and L. Borgstrom. 2002. In vitro testing of pharmaceutical aerosols and predicting lung deposition from in vitro measurements. In H. Bisgaard, C. O'Callaghan, and G.C. Smaldone, eds. Drug Delivery to the Lung. Marcel Dekker, New York, 105-142.
40. Lin, T.-C., P.N. Breysse, L.L. Beth, et al. 2001. Mouthpiece diameter affects deposition efficiency in cast models of the human oral airways. J. Aerosol Med. 14:335-341.
41. Finlay, W.H., W. De Haan, B. Grgic, et al. 2002. Fluid mechanics and particle deposition in the oropharynx: the factors that really matter. In Respiratory Drug Delivery VIII. Davis Horwood International, Tucson.
42. Zhang, Y., W.H. Finlay, and E.A. Matida. 2004. Particle deposition measurements and numerical simulation in a highly idealized mouth-throat. J. Aerosol Sci. 35:789-803.
43. Cheng, Y.-S., Y. Zhou, and B.T. Chen. 1999. Particle deposition in a cast of human oral airways. Aerosol Sci. Technol. 31:286-300.
44. Cheng, Y.S., D. Yazzie, B.S. Gao, et al. 2003. Particle characteristics and lung deposition patterns in a human airway replica of a dry powder formulation of polyactic acid produced using supercritical fluid technology. J. Aerosol Med. 16:65-73.
45. McRobbie, D.W., S. Pritchard, and R.A. Quest. 2003. Studies of the human oropharyngeal airspaces using magnetic resonance imaging. I. Validation of a three-dimensional MRI method for producing ex vivo virtual and physical casts of the oropharyngeal airways during inspiration. J. Aerosol Med. 16:401-415.
46. Heenan, A.F., W.H. Finlay, B. Grgic, et al. 2004. An investigation of the relationship between the flow field and regional deposition in realistic extra-thoracic airways. J. Aerosol Sci. 35:1013-1023.
47. Grgic, B., W.H. Finlay, P.K.P. Burnell, et al. 2004. In vitro intersubject and intrasubject deposition measurements in realistic mouth-throat geometries. J. Aerosol Sci. 35:1025-1040.
48. Fleming, J.S., V. Sauret, J.H. Conway, et al. 2004. Validation of the conceptual anatomical model of the lung airway. J. Aerosol Med. 17:260-269.